Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7386-7394

  Zanon, Marina ^a   Piris, Adriano ^a   Bersani, Ilaria ^a   Vegetti, Claudia ^a   Molla, Alessandra ^a   Scarito, Alessia ^a   Anichini, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETULIC ACID; CAMPTOTHECIN; CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; CELECOXIB; CISPLATIN; ETOPOSIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN P53; STAUROSPORINE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA CELL; NEWBORN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA ANALYSIS; WILD TYPE;

AMIDINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; BENZYLAMINES; CAMPTOTHECIN; CASPASE 9; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA; PROTEIN BIOSYNTHESIS; PROTEINS; PYRAZOLES; RNA, MESSENGER; SULFONAMIDES;

EID: 5644293078     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1640     Document Type: Article

References (45)

1. Nathan FE, Mastrangelo MJ. Systemic therapy in melanoma. Semin Surg Oncol 1998;14:319-27.
2. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22:3138-51.
3. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
4. Hengartner MO. The biochemistry of apoptosis. Nature (Lond) 2000;407:770-6.
5. Hussein MR, Haemel AK, Wood GS. Apoptosis and melanoma: molecular mechanisms. J Pathol 2003;1299:275-88.
6. Medema JP, De Jong J, Peltenburg LT, et al. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA 2001;98: 11515-20.
7. Soengas MS, Capodieci P, Polsky D, et al. Inactivation of the apoptosis effector APAF-1 in malignant melanoma. Nature (Lond) 2001;409:207-11.
8. Robles AI, Bemmels NA, Foraker AB, Harris CC. APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis. Cancer Res 2001;61:6660-4.
9. Fortin A, Cregan SP, MacLaurin JG, et al. APAF-1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J Cell Biol 2001;155:207-16.
10. Yoshida H. The role of APAF-1 in programmed cell death: from worm to tumor. Cell Struct Funct 2003;28:3-9.
11. Li P, Nijhawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91: 479-89.
12. Cain K, Bratton SB, Cohen GM. The APAF-1 apoptosome: a large caspase-activating complex. Biochimie 2002;84:203-14.
13. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274: 11549-56.
14. Yoshida H, Kong YY, Yoshida R, et al. APAF-1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998;94:739-50.
15. Soengas MS, Alarcon RM, Yoshida H, et al. APAF-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (Wash DC) 1999;284:156-9.
16. Lassus P, Opitz-Araya X, Lazebnik Y. Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization. Science (Wash DC) 2002;297: 1352-4.
17. Marsden VS, O'Connor L, O'Reilly LA, et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/APAF-1/caspase-9 apoptosome. Nature (Lond) 2002;419:634-7.
18. Belmokhtar CA, Hillion J, Dudognon C, et al. Apoptosome-independent pathway for apoptosis. Biochemical analysis of APAF-1 defects and biological outcomes. J Biol Chem 2003;278:29571-8.
19. Anichini A, Mortarini R, Maccalli C, et al. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A2.1-restricted immune repertoire to melanoma. J Immunol 1996;156:208-17.
20. Anichini A, Mazzocchi A, Fossati G, Parmiani G. Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. J Immunol 1989;142:3692-701.
21. Salvucci O, Carsana M, Bersani I, Tragni G, Anichini A. Antiapoptotic role of endogenous nitric oxide in human melanoma cells. Cancer Res 2001;61:318-26.
22. Benedict MA, Hu Y, Inohara N, Núñez G. Expression and functional analysis of APAF-1 isoforms. J Biol Chem 2000;275:8461-8.
23. Maccalli C, Pisarra P, Vegetti C, Sensi M, Parmiani G, Anichini A. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions. J Immunol 1999;163:6912-23.
24. Daniotti M, Oggionni M, Ranzani T, et al. BRAF Alterations are associated with complex mutational profiles in malignant melanoma. Oncogene 2004;23:5968-77.
25. Kaufmann SH. Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim Biophys Acta 1998;1400:195-211.
26. Jendrossek V, Handrick R, Belka C. Celecoxib activates a novel mitochondrial apoptosis signaling pathway. FASEB J 2003;17:1547-9.
27. Arico S, Pattingre S, Bauvy C, et al. Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line. J Biol Chem 2002;277:27613-21.
28. Moroni MC, Hickman ES, Lazzerini Denchi E, et al. APAF-1 is a transcriptional target for E2F and p53. Nat Cell Biol 2001;3:552-8.
29. McDonnel MA, Wang D, Khan SM, Vander Heiden MG, Kelekar A. Caspase-9 is activated in a cytochrome c-independent manner early during TNF-alpha-induced apoptosis in murine cells. Cell Death Differ 2003;10:1005-15.
30. Del Bello B, Valentini MA, Mangiavecchi P, Comporti M, Maellaro E. Role of caspases-3 and -7 in APAF-1 proteolytic cleavage and degradation events during cisplatin-induced apoptosis in melanoma cells. Exp Cell Res 2004;293:302-10.
31. Baldi A, Santini D, Russo P, et al. Analysis of APAF-1 expression in human cutaneous melanoma progression. Exp Dermatol 2004;13:93-7.
32. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 2002;277: 3247-57.
33. Bartke T, Siegmund D, Peters N, et al. p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells. Oncogene 2001;20:571-80.
34. Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N, Givol D. DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of. APAF-I. Oncogene 2001;20:3449-55.
35. Laubert K, Appel HAE, Schlosser SF, Gregor M, Schulze-Osthoff K, Wesselborg S. The adapter protein apoptotic protease-activating factor-1 (APAF-1) is proteolytically processed during apoptosis. J Biol Chem 2001;276:29772-81.
36. van Gurp M, Festjens N, van Loo G, Saelens X, Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 2003;304: 487-97.
37. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 2001;20:1063-75.
38. Friesen C, Fulda S, Debatin KM. Cytotoxic drugs and the CD95 pathway. Leukemia 1999;13:1854-8.
39. Lin MT, Lee RC, Yang PC, Ho FM, Kuo ML. Cyclooxigenase-2 inducing Mc-1-dependent survival mechanism in human lung adenocarcinoma CL 1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 2001;276: 48997-9002.
40. Ho AT, Li QH, Hakem R, Mak TW, Zacksenhaus E. Coupling of caspase-9 to APAF-1 in response to loss of pRb or cytotoxic drugs is cell-type-specific. EMBO J 2004;23:460-72.
41. Bitzer M, Armeanu S, Prinz F, et al. Caspase-8 and APAF-1- independent caspase-9 activation in Sendai virus-infected cells. J Biol Chem 2002;277:29817-24.
42. Liu JR, Opipari AW, Tan L, et al. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res 2002;62:924-31.
43. Shinoura N, Sakurai S, Asai A, Kirino T, Hamada H. Co-transduction of APAF-1 and caspase-9 augments etoposide-induced apoptosis in U-373MG glioma cells. Jpn J Cancer Res 2001;92:467-74.
44. Martinsson P, Liminga G, Nygren P, Larsson R. Characteristics of etoposide-induced apoptotic cell death in the U-937 human lymphoma cell lines. Anticancer Drugs 2001;12:699-705.
45. Engels IH, Stepczynska A, Stroh C, et al. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000;19:4563-73.